- Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.
Althouse BM, Durbin AP, Hanley KA, Halstead SB, Weaver SC, Cummings DA.
Virology, 2014; 452-453: 237-46.
doi: 10.1016/j.virol.2014.01.015
- Demographic, clinical and laboratory findings among adult and pediatric patients hospitalized with dengue in the Philippines.
Velasco JM, Alera MT, Ypil-Cardenas CA, Dimaano EM, Jarman RG, Chinnawirotpisan P, Thaisomboonsuk B, Yoon IK, Cummings DA, Mammen MP Jr.
Southeast Asian J Trop Med Public Health, 2014; 45: 337-45..
doi:
- A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand.
Anderson KB, Gibbons RV, Cummings DA, Nisalak A, Green S, Libraty DH, Jarman RG, Srikiatkhachorn A, Mammen MP, Darunee B, Yoon IK, Endy TP.
J Infect Dis, 2014; 209: 360-8.
doi: 10.1093/infdis/jit436
- Potential opportunities and perils of imperfect dengue vaccines.
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Schwartz IB, Burke DS, Cummings DA.
Vaccine, 2014; 32: 514-20.
doi: 10.1016/j.vaccine.2013.11.020
- Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates.
Mier-y-Teran-Romero L, Schwartz IB, Cummings DA.
J Theor Biol, 2013; 332: 203-10.
doi: 10.1016/j.jtbi.2013.04.036
- Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity.
Reich NG, Shrestha S, King AA, Rohani P, Lessler J, Kalayanarooj S, Yoon IK, Gibbons RV, Burke DS, Cummings DA.
J R Soc Interface, 2013; 10: 20130414.
doi: 10.1098/rsif.2013.0414
- Challenges in the interpretation of dengue vaccine trial results.
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Burke DS, Cummings DA.
PLoS Negl Trop Dis, 2013; 7: e2126.
doi: 10.1371/journal.pntd.0002126
- Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation
Live Dengue Vaccines Technical Consultation Reporting Group (including Cummings DAT), Bentsi-Enchill AD, Schmitz J, Edelman R, Durbin A, Roehrig JT, Smith PG, Hombach J, Farrar J.
Vaccine, 2013: 31(23):2603-9.
https://doi.org/10.1016/j.vaccine.2013.03.038
- Synchrony of sylvatic dengue isolations: a multi-host, multi-vector SIR model of dengue virus transmission in Senegal.
Althouse BM, Lessler J, Sall AA, Diallo M, Hanley KA, Watts DM, Weaver SC, Cummings DA.
PLoS Negl Trop Dis, 2012; 6: e1928.
doi: 10.1371/journal.pntd.0001928
- Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.
Rainwater-Lovett K, Rodriguez-Barraquer I, Cummings DA, Lessler J.
BMC Infect Dis, 2012; 12: 233.
doi: 10.1186/1471-2334-12-233
- Revealing the microscale spatial signature of dengue transmission and immunity in an urban population.
Salje H, Lessler J, Endy TP, Curriero FC, Gibbons RV, Nisalak A, Nimmannitya S, Kalayanarooj S, Jarman RG, Thomas SJ, Burke DS, Cummings DA.
Proc Natl Acad Sci U S A, 2012; 109: 9535-8.
doi: 10.1073/pnas.1120621109
- Assessing the potential of a candidate dengue vaccine with mathematical modeling.
WHO-VMI Dengue Vaccine Modeling Group, Beatty M, Boni MF, Brown S, Buathong R, Burke D, Coudeville L, Cummings DA, Edelman R, Farrar J, Focks DA, Gomes MG, Guignard A, Halstead S, Hombach J, Knerer G, Koelle K, Lam FC, Lang J, Longini I, Medlock J, Namgyal P, et al.
PLoS Negl Trop Dis, 2012; 6: e1450.
doi: 10.1371/journal.pntd.0001450
- Models of the impact of dengue vaccines: a review of current research and potential approaches.
Johansson MA, Hombach J, Cummings DA.
Vaccine, 2011; 29: 5860-8.
doi: 10.1016/j.vaccine.2011.06.042
- Prediction of dengue incidence using search query surveillance.
Althouse BM, Ng YY, Cummings DA.
PLoS Negl Trop Dis, 2011; 5: e1258.
doi: 10.1371/journal.pntd.0001258
- Decay and persistence of maternal dengue antibodies among infants in Bangkok.
van Panhuis WG, Luxemburger C, Pengsaa K, Limkittikul K, Sabchareon A, Lang J, Durbin AP, Cummings DA.
Am J Trop Med Hyg, 2011; 85: 355-62.
doi: 10.4269/ajtmh.2011.11-0125
- Economic value of dengue vaccine in Thailand.
Lee BY, Connor DL, Kitchen SB, Bacon KM, Shah M, Brown ST, Bailey RR, Laosiritaworn Y, Burke DS, Cummings DA.
Am J Trop Med Hyg, 2011; 84: 764-72.
doi: 10.4269/ajtmh.2011.10-0624
- From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil.
Rodriguez-Barraquer I, Cordeiro MT, Braga C, de Souza WV, Marques ET, Cummings DA.
PLoS Negl Trop Dis, 2011; 5: e935.
doi: 10.1371/journal.pntd.0000935
- Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.
van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, Nisalak A, Burke DS, Cummings DA.
J Infect Dis, 2010; 202: 1002-10.
doi: 10.1086/656141
- Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006.
Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, Jarman RG, Green S, Rothman AL, Cummings DA.
PLoS Negl Trop Dis, 2010; 4: e617.
doi: 10.1371/journal.pntd.0000617
- Multi-year climate variability and dengue: El Niño Southern Oscillation, Weather, and Dengue Incidence in Puerto Rico, Mexico, and Thailand.
Johansson M, Cummings DAT, Glass G.
PLoS Medicine, 2009: 6:e1000168.
https://doi.org/10.1371/journal.pmed.1000168
